The cohort included sporadic PD (397, 95%), PD with GBA1 pathogenic sequence variants (13, 3%), PD with LRRK2 G2019S variation (6, 1%), and PD with GBA1 + LRRK2 mutation (1, 0.2%). The gene discussed is GBA1; the disease is Parkinson disease.